SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. Ramle who wrote (3451)7/22/1999 1:00:00 AM
From: M. Ramle  Read Replies (2) of 10280
 
To Dave (rupeh) on the YC:

I also had the opportunity to attend the SEPR's Investors' Luncheon yesterday, and I personally found it very interesting. It was very obvious that the products in the pipeline seem to be a lot more exciting than what has been publicly stated in the sense of functions, partnerships and projected launch dates.

The one thing that stuck in my mind after the meeting was my question to David Southwell about SEPR's positive earnings expectancy, and he seemed to feel very comfortable with 2001. That is why he was very convincingly assuring that their R&D expenditures are very controllable.

He also did say that most executive management's net worth was held in stock options, which obviously means that it is to their best interest to see the price of their stock rise, and that is why I personally believe that they have their product pipeline and R&D expenditures under control. All in all, I was very impressed with Southwell's presentation and with SEPR's pipeline which looks extremely promising. Good Luck.

Mazen
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext